...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The Prescription

I'm not going to look a gift horse in the mouth....its great that Resverlogix finally has, what certainly appears to be, completely independent analyst coverage.  But we're not seeing much impact, at least not yet....still stuck in and around the $1.30 mark.

Hopefully the damn is breaking and this is just the start...I don't know what the shelf life of a report like this is, but I can't imagine its too long.  

Share
New Message
Please login to post a reply